# A Study to Determine Eligibility for CAH-301 (A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH) [NCT04783181])

> **NCT05101902** · — · COMPLETED · sponsor: **Adrenas Therapeutics Inc** · enrollment: 65 (actual)

## Conditions studied

- Congenital Adrenal Hyperplasia

## Interventions

- **OTHER:** Pre-Screening

## Key facts

- **NCT ID:** NCT05101902
- **Lead sponsor:** Adrenas Therapeutics Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-01
- **Primary completion:** 2024-08-07
- **Final completion:** 2024-08-07
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05101902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05101902, "A Study to Determine Eligibility for CAH-301 (A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH) [NCT04783181])". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05101902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*